Mediterranean, MIND, and ketogenic dietary patterns in Parkinson's disease: evidence from a recent review
A 2026 narrative review examined how Mediterranean, MIND, and ketogenic dietary patterns might influence motor and non‑motor manifestations of Parkinson's disease. The authors report that antioxidant‑rich Mediterranean eating, ketone‑producing ketogenic regimens, and cognition‑focused MIND diets each show signals of benefit, but direct comparative trials are scarce.
Study and findings
The authors performed a narrative synthesis of recent literature on three dietary patterns—Mediterranean, MIND, and ketogenic—in the context of Parkinson's disease (PD). They describe the Mediterranean diet as high in fruits, vegetables, whole grains, olive oil, and fish, providing antioxidants and anti‑inflammatory nutrients that may alleviate motor symptoms and potentially slow neurodegeneration. The ketogenic diet, characterized by high fat and low carbohydrate intake that induces ketosis, is reported to improve motor function in small experimental and clinical reports, presumably via neuroprotective actions of ketone bodies. The MIND diet, which combines elements of Mediterranean and DASH diets and emphasizes leafy greens, berries, and nuts, is highlighted for its documented cognitive benefits, suggesting it could mitigate PD‑related cognitive decline. Across the three patterns, the review notes a consistent theme: dietary modulation may influence disease‑related pathways, yet the authors acknowledge that robust, disease‑specific trials are lacking.
Clinical interpretation
For clinicians, the review suggests that encouraging a balanced, antioxidant‑rich diet such as the Mediterranean pattern could be a low‑risk adjunct to standard PD therapy, potentially supporting motor and non‑motor symptom control. The ketogenic approach may be considered in selected patients who can tolerate high fat intake and achieve stable ketosis, but its application remains experimental pending larger efficacy data. The MIND diet offers a pragmatic option for patients concerned about cognitive decline, aligning with broader recommendations for brain health. Importantly, none of the patterns can be presented as disease‑modifying treatments at this stage; they should be framed as supportive nutritional strategies whose benefits are inferred from limited and heterogeneous evidence.
Limitations and open questions
The review is limited by the paucity of randomized controlled trials directly comparing these diets in PD populations, reliance on small pilot studies, and heterogeneity in diet definitions and outcome measures. Most cited data derive from observational cohorts or short‑term interventions, which restrict causal inference. Open questions include the optimal macronutrient composition for neuroprotection, long‑term safety of sustained ketosis in older adults, and whether combined dietary patterns could produce additive effects. Future research will need well‑designed, adequately powered trials with standardized clinical endpoints to clarify the true impact of these diets on disease progression and quality of life.
Source
The editorial is based on a 2026 narrative review of Mediterranean, MIND, and ketogenic diets in Parkinson's disease (PMID 42955473).